Coleman Glenn
EVP & Chief Financial Officer
Coleman Glenn has filed 5 SEC Form 4 filings (7 transaction rows) across 2 companies, including CRL, PINC, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Oct 2, 2026.
On the most recent filing, Coleman Glenn is listed as EVP & Chief Financial Officer at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Inside the rolling window, Coleman Glenn reported 1 open-market purchase totaling $3K in CRL and no open-market sales.
Companies traded
Other insiders at CRL
Insider Buying
$3K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Coleman Glenn made?
Coleman Glenn has filed 5 SEC Form 4 filings (7 transaction rows) across 2 companies, including CRL, PINC since 2025.
Which companies does Coleman Glenn trade?
Coleman Glenn has filed SEC Form 4 disclosures for 2 companies, including CRL, PINC.
When was Coleman Glenn's most recent SEC Form 4 filing?
Coleman Glenn's most recent SEC Form 4 filing on Tracefour is dated Oct 2, 2026.
What is Coleman Glenn's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Coleman Glenn is listed as EVP & Chief Financial Officer.
What is Coleman Glenn's total buy and sell value in the current window?
Inside the rolling retention window, Coleman Glenn bought $3K and sold $0 based on SEC Form 4 filings.
What was Coleman Glenn's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 10 CRL shares on 2026-09-30, worth $3K, per SEC Form 4 filings.